Porter Rheumatology Ltd /ID# 200421

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Psoriasis
• Psoriatic arthritis

Closed trials

• Completed

  A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)

  NCT03104400· Phase 3· AbbVie· Source